Author Archives: Pablo Martinez

Roma

iHIVARNA in the “10th Euro Global Summit and Expo on Vaccines & Vaccination”

iHIVARNA in the “10th Euro Global Summit and Expo on Vaccines & Vaccination”

Dr. Felipe García, the iHIVARNA Project Coordinator, has been invited to participate as speaker at the workshop on the topic “Revisiting HIV inactivation , elite controllers, immunogenetics and HIV therapeutic vaccines” organized at the 10th Euro Global Summit and Expo on Vaccines & Vaccination (Euro Vaccines 2016). The above-mentioned symposium will take place in Rome

EACS 2015

iHIVARNA in the 15th European AIDS Conference – EACS

iHIVARNA Project’s Scientific Coordinator, Dr. Felipe Garcia, was invited to present the project’s status and some of the preclinical results obtained during the first phase of the iHIVARNA’s trials in the parallel session “Prospects for HIV Cure and Post Treatment Remission” during the last EACS conference. The European AIDS Clinical Society (EACS) held its 15th

ITM - Antwerp

4th General Assembly Meeting

The iHIVARNA Project’s 4th General Assembly Meeting has been held last 21-22 of September in the Antwerp Institute of Tropical Medicine. The General Assembly meetings take place twice per year and include senior representatives from each partner of the iHIVARNA project.   The meeting was focused on two main topics: 1) updating the status of

IAS-2015

iHIVARNA contribution at IAS 2015 Symposium and the 8th International AIDS Society Conference (Vancouver, 18-23 July)

On 2015 July 18-19 and 20 -23 were held in Vancouver, Canada, the “IAS 2015 Towards an HIV Cure Symposium” and the “8th International AIDS Society Conference on HIV pathogenesis, treatment and Prevention”. iHIVARNA consortium presented a study entitled “Monocyte-derived DC Electroporated with mRNAs Encoding both specific HIV Antigens and DC Adjuvants are able to

news_20150519

iHIVARNA in “Towards an HIV Cure” and “IAS Conference”

Dr. Felipe García, the iHIVARNA Project Coordinator, has been invited to present in the “2015 Towards an HIV Cure” and “The 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention” the results from the work entitled “Monocyte-derived DC electroporated with mRNAs encoding both specific HIV antigens and DC adjuvants are able to improve T-cell functionality”.

DSC_0001

iHIVARNA 3rd General Assembly meeting

The 3rd General Assembly meeting has been held last 9-10 of March in Barcelona. The General Assembly meetings take place twice per year and include senior representatives from each partner of the iHIVARNA project. During the first day of the meeting it was organized a special session with the Scientific Advisory Board members Xavier Carné,

vih

Contribution at HIV Research for Prevention 2014 (Cape Town, 28-31 October)

The contribution was accepted for poster presentation at HIV Research for Prevention 2014 (Cape Town, 28-31 October). iHIVARNA reported the in vitro results of the immunogenicity assays performed with different mRNA combination sequences: HIVACAT mRNA sequence and TriMix mRNA sequences. In summary mRNA Electroporation of DCs (HIVACAT+Trimix) improved their maturation status and was able to enhance HIV

Top